K. Jacobson

发表

Dynamics of isoproterenol subsensitivity in guinea pig airway smooth muscle

H. Nelson, W. R. Tipton, H. G. Morris, 1981, Lung.

Links between Pollen, Atopy and the Asthma Epidemic

J. House, P. Taylor, M. Glovsky, 2007, International Archives of Allergy and Immunology.

Intranasal therapy with once-daily triamcinolone acetonide aerosol versus twice-daily beclomethasone dipropionate aqueous spray in patients with perennial allergic rhinitis

D. Webb, T. Casale, W. Pleskow, 1996 .

Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.

D. Banerji, T. Uryniak, R. Kane, 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema.

J. Bernstein, W. Lumry, J. Schranz, 2014, The journal of allergy and clinical immunology. In practice.

The effect of theophylline on the lower esophageal sphincter pressure.

H. Nelson, R. Weber, L. Mansfield, 1980, Annals of allergy.

Triamcinolone Acetonide Aqueous Nasal Inhaler for the Treatment of Spring Grass Seasonal Allergic Rhinitis in Children

R. Kobayashi, G. Settipane, E. Schenkel, 1997 .

Laboratory tests in chronic urticaria.

H. Nelson, K. Jacobson, L. B. Branch, 1980, JAMA.

C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks – final results of the I.M.P.A.C.T.2 study

T. Machnig, T. Craig, R. Wasserman, 2011, Allergy.

C1 Esterase Inhibitor (C1-INH) Concentrate in the Treatment of Acute Attacks in Hereditary Angioedema: Interim Results of the Treatment of 975 Attacks in an Ongoing, Prospective, Open-Label Study in North America (I.M.P.A.C.T.2)

William H. Yang, T. Craig, R. Wasserman, 2010 .

Repeat treatment of acute hereditary angioedema attacks with open‐label icatibant in the FAST‐1 trial

W. Lumry, B. Ritchie, J. Hébert, 2014, Clinical and experimental immunology.

Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.

T. Machnig, J. Bernstein, T. Craig, 2012, Allergy and asthma proceedings.

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

William H. Yang, P. Keith, P. Schmid‐Grendelmeier, 2010, The New England journal of medicine.

Per-Attack Reporting of Prodromal Symptoms Concurrent with C1-Inhibitor Treatment of Hereditary Angioedema Attacks

T. Machnig, T. Craig, R. Wasserman, 2012, Advances in Therapy.

A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema

Moshe Y. Vardi, E. Aygören‐Pürsün, I. Martínez-Saguer, 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings

E. Aygören‐Pürsün, I. Martínez-Saguer, J. Schranz, 2017, International Archives of Allergy and Immunology.

C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.

T. Machnig, T. Craig, R. Wasserman, 2012, Allergy and asthma proceedings.

Abstracts from the 10th C1-inhibitor deficiency workshop

William H. Yang, A. Szilágyi, M. Margaglione, 2017, Allergy, Asthma & Clinical Immunology.

Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema

W. Lumry, J. Schranz, H. Li, 2015, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

C1 INHIBITOR ADMINISTRATION IN PEDIATRIC PATIENTS WITH HEREDITARY ANGIOEDEMA: PATIENT COMPLIANCE WITH INTRAVENOUS THERAPY

Moshe Y. Vardi, E. Aygören‐Pürsün, I. Martínez-Saguer, 2018, Annals of Allergy, Asthma & Immunology.

C1 Esterase Inhibitor Concentrate (C1-INH) for the Treatment of Acute Attacks of Hereditary Angioedema: Interim Results of an Ongoing, Prospective, Open Label Study in North America after 640 attacks (I.M.P.A.C.T.2)

William H. Yang, R. Wasserman, J. Moy, 2009 .

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.

W. Busse, G. Colice, J. V. Vanden Burgt, 1999, The Journal of allergy and clinical immunology.

EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis

J. Palmer, C. Kosik‐Gonzalez, P. Djupesland, 2018, International forum of allergy & rhinology.

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

William H. Yang, P. Keith, P. Schmid‐Grendelmeier, 2010, The New England journal of medicine.

C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks – final results of the I.M.P.A.C.T.2 study

T. Machnig, M. Rojavin, R. Levy, 2011, Allergy.